Urology
Volume 77, Issue 2 , Pages 439-445 , February 2011

Intravesical Electromotive Botulinum Toxin Type A Administration—Part II: Clinical Application

  • Abdol-Mohammad Kajbafzadeh

      Affiliations

    • Pediatric Urology Research Center, Department of Pediatric Urology, Children's Hospital, Tehran University of Medical Sciences, Tehran, Iran
    • Corresponding Author InformationReprint requests: Abdol-mohammad Kajbafzadeh, M.D., Pediatric Urology Research Center, Department of Pediatric Urology, Children's Hospital and Medical Center, Tehran University of Medical Sciences, 32, 2nd Floor, Seventh Street, Saadat-Abad Avenue, Tehran 1998714616 Iran
    • ,
  • Hamed Ahmadi

      Affiliations

    • Pediatric Urology Research Center, Department of Pediatric Urology, Children's Hospital, Tehran University of Medical Sciences, Tehran, Iran
    • ,
  • Laleh Montaser-Kouhsari

      Affiliations

    • Pediatric Urology Research Center, Department of Pediatric Urology, Children's Hospital, Tehran University of Medical Sciences, Tehran, Iran
    • ,
  • Lida Sharifi-Rad

      Affiliations

    • Department of Physical Therapy, Children's Hospital, Tehran University of Medical Sciences, Tehran, Iran
    • ,
  • Farideh Nejat

      Affiliations

    • Department of Neurosurgery, Children's Hospital, Tehran University of Medical Sciences, Tehran, Iran
    • ,
  • Shahrzad Bazargan-Hejazi

      Affiliations

    • Department of Psychiatry and Human Behavior, Charles R. Drew University of Medicine and Sciences, Los Angeles, California
    • Department of Pediatrics, Charles R. Drew University of Medicine and Sciences, Los Angeles, California

Received 22 February 2010 ,Revised 4 June 2010

References 

  1. Altaweel W , Jednack R , Bilodeau C , et al.   Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele . J Urol . 2006;175:1102–1105
  2. Kajbafzadeh AM , Moosavi S , Tajik P , et al.   Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele . Urology . 2006;68:1091–1097
  3. Schurch B , Corcos J . Botulinum toxin injections for paediatric incontinence . Curr Opin Urol . 2005;15:264–267
  4. Shoshan L , Ben-Zvi D , Katz-Leurer M . Use of the anal plug in the treatment of fecal incontinence in patients with meningomyelocele . J Pediatr Nurs . 2008;23:395–399
  5. Neel KF , Soliman S , Salem M , et al.   Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder . J Urol . 2007;178:2593–2598
  6. Apostolidis A , Dasgupta P , Fowler CJ . Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity . Eur Urol . 2006;49:644–650
  7. Schulte-Baukloh H , Michael T , Schobert J , et al.   Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results . Urology . 2002;59:325–328
  8. Schulte-Baukloh H , Michael T , Sturzebecher B , et al.   Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder . Eur Urol . 2003;44:139–143
  9. Riccabona M , Koen M , Schindler M , et al.   Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia . J Urol . 2004;171:845–848
  10. Neel KF , Salem M , Soliman S . Total endoscopic management (TEM approach) of children with non-compliant neuropathic bladder: a preliminary report . J Pediatr Urol . 2008;4:124–126
  11. Semalty A , Semalty M , Singh R , et al.   Iontophoretic drug delivery system: a review . Technol Health Care . 2007;15:237–245
  12. Di Stasi SM , Giannantoni A , Vespasiani G , et al.   Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens . J Urol . 2001;165:491–498
  13. Dasgupta P , Fowler CJ , Stephen RL . Electromotive drug administration of lidocaine to anesthetize the bladder before intravesical capsaicin . J Urol . 1998;159:1857–1861
  14. Schurch B , Stohrer M , Kramer G , et al.   Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? (Preliminary results) . J Urol . 2000;164:692–697
  15. Palmer LS , Richards I , Kaplan WE . Transrectal electrostimulation therapy for neuropathic bowel dysfunction in children with myelomeningocele . J Urol . 1997;157:1449–1452
  16. Gurpinar T , Truong LD , Wong HY , et al.   Electromotive drug administration to the urinary bladder: an animal model and preliminary results . J Urol . 1996;156:1496–1501
  17. Riedl CR , Knoll M , Plas E , et al.   Intravesical electromotive drug administration technique: preliminary results and side effects . J Urol . 1998;159:1851–1856
  18. Giannantoni A , Di Stasi SM , Chancellor MB , et al.   New frontiers in intravesical therapies and drug delivery . Eur Urol . 2006;50:1183–1193
  19. Kavanagh GM , Oh C , Shams K . Botox delivery by iontophoresis . Br J Dermatol . 2004;151:1093–1095
  20. Jewett MA , Valiquette L , Sampson HA , et al.   Electromotive drug administration of lidocaine as an alternative anesthesia for transurethral surgery . J Urol . 1999;161:482–485
  21. Albavera-Hernandez C , Rodriguez JM , Idrovo AJ . Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials . Clin Rehabil . 2009;23:394–407
  22. Akbar M , Abel R , Seyler TM , et al.   Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction . BJU Int . 2007;100:639–645
  23. DasGupta R , Murphy FL . Botulinum toxin in paediatric urology: a systematic literature review . Pediatr Surg Int . 2009;25:19–23
  24. Hoebeke P , De Caestecker K , Vande Walle J , et al.   The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor . J Urol . 2006;176:328–330 321
  25. Karsenty G , Reitz A , Lindemann G , et al.   Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity . Urology . 2006;68:1193–1197
  26. Schulte-Baukloh H , Knispel HH , Stolze T , et al.   Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity . Urology . 2005;66:865–870
  27. Shapiro E , Seller MJ , Lepor H , et al.   Altered smooth muscle development and innervation in the lower genitourinary and gastrointestinal tract of the male human fetus with myelomeningocele . J Urol . 1998;160:1047–1053 1079
  28. Coggrave M . Neurogenic continence (part 3: Bowel management strategies) . Br J Nurs . 2008;17:962–968
  29. Kajbafzadeh AM , Sina AR , Moradi A , et al.   Laparoscopic antegrade continent enema through VQ stoma skin flaps using two ports: long-term follow-up . J Endourol . 2007;21:78–82
  30. Karsenty G , Elzayat E , Delapparent T , et al.   Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux . J Urol . 2007;177:1011–1014

PII: S0090-4295(10)00787-9

doi: 10.1016/j.urology.2010.06.003

Urology
Volume 77, Issue 2 , Pages 439-445 , February 2011

Article Tools

* Image Usage & Resolution